This is a sources sought notice. The Defense Logistics Agency (DLA) Troop Support is seeking sources capable of providing Abbott’s cardiovascular product line that fall into the following product categories; Atrial Fibrillation, Coronary, Cardiac Rhythm Management, Endovascular, Heart Failure Management, Mechanical Circulatory Support, Neuromodulation Devices, and Structural Heart Devices. Along with these products or products in these categories the vendor must be capable of supplying the ancillary accessories (such as needles for entry and guide wire) and instrumentation that are necessary for the physician to perform cardiovascular surgery. All products must be Food and Drug Administration (FDA) approved. The cardiovascular products must be delivered Just-In-Time (JIT), Direct Vendor Delivery (DVD) and Consignment. Under the JIT delivery method, the Medical Treatment Facility (MTF) calls the manufacturer’s field representative who carriers the products into the MTF just-in-time for the surgery. The manufacturer’s sales representative may bring many sizes and types of implants and other auxiliary products to the surgery along with the instrumentation sets. Under the DVD method an order for products is placed through ECAT and the products and the products are delivered direct to the customer via any transportation carrier. Under the consignment method an Medical Treatment (MTF’s) will have the products consigned to their facility. At the request of the MTF’s, the manufacturer is required to have a qualified representative on site at the MTF’s within the timeframe specified by the facility necessary to meet their requirements. The manufacturer’s representative’s provides technical advice and guidance to the physician’s before, during and after implantation. Furthermore, technical support is available twenty-four (24) hours a day, seven (7) days a week. This is a Request For Information (RFI) and does not commit the U.S. Government to issue a solicitation, make an award or pay any costs associated with responding to this announcement. All submitted information shall remain with the U.S. Government and will not be returned. Your response to this RFI shall be submitted electronically in PDF format and emailed to
[email protected]